Acadia Pharmaceuticals (ACAD) Goodwill & Intangibles (2016 - 2026)

Acadia Pharmaceuticals' Goodwill & Intangibles history runs 10 years deep, the most recent figure standing at $106.2 million for Q1 2026.

• In Q1 2026, Goodwill & Intangibles fell 9.3% year-over-year to $106.2 million; the TTM figure through Mar 2026 stood at $106.2 million (down 9.3% YoY), while the FY2025 annual figure was $108.9 million, down 9.09% from the prior year.
• Goodwill & Intangibles was $106.2 million for Q1 2026 at Acadia Pharmaceuticals, down from $108.9 million in the prior quarter.
• In the past five years, Goodwill & Intangibles ranged from a high of $119.8 million in Q4 2024 to a low of $65.5 million in Q4 2023.
• Historically, Goodwill & Intangibles has averaged $98.5 million across 4 years, with a median of $107.9 million in 2024.
• The sharpest annual moves came in 2024 and 2026: Goodwill & Intangibles surged 82.9% in 2024, then slipped 9.3% in 2026.
• A 4-year view of Goodwill & Intangibles shows it stood at $65.5 million in 2023, then jumped by 82.9% to $119.8 million in 2024, then fell by 9.09% to $108.9 million in 2025, then retreated by 2.5% to $106.2 million in 2026.
• The last three Goodwill & Intangibles figures came in at $106.2 million (Q1 2026), $108.9 million (Q4 2025), and $111.6 million (Q3 2025), per Business Quant data.